| Literature DB >> 34057596 |
Niels Hansen1, Daniel Luedecke2, Berend Malchow3, Michael Lipp2, Jonathan Vogelgsang3, Charles Timäus3, Tristan Zindler4, Stefan Gingele5, Simone Kühn2, Jürgen Gallinat2, Klaus Wiedemann2, Johannes Denk2, Nicole Moschny4, Jens Fiehler6, Thomas Skripuletz5, Christian Riedel7, Mike P Wattjes8, Inga Zerr9, Hermann Esselmann3, Luise Poustka10, Anne Karow2, Hans Hartmann11, Helge Frieling4, Stefan Bleich4, Jens Wiltfang3,12,13, Alexandra Neyazi4.
Abstract
Studies show that psychiatric symptoms in adults and children are sometimes associated with serum neural autoantibodies. The significance of serum neural autoantibodies associated with psychiatric symptoms in children remains often unclear, but might be relevant for the extent and occurrence of psychiatric disease manifestation in later life, as well as therapy and outcome. For this narrative review, we sought articles listed in PubMed and published between 1988 and 2020 addressing the maternal-fetal transfer of neural autoantibodies and psychiatric disorders associated with serum neural autoantibodies. We identified six major subgroups of psychiatric disorders in children that are associated with serum neural autoantibodies: patients with attentional deficit hyperactivity disorder, autism spectrum disorder, obsessive compulsive disorder, Gilles de la Tourette syndrome, psychosis and catatonia. Furthermore, we summarized study findings from maternal-fetal transfer of Contactin-associated protein-like 2, N-methyl-D-aspartate receptor and fetal brain autoantibodies associated with behavioral effects in animals and humans. We hypothesize that the maternal transfer of serum neuronal autoantibodies during or after birth could result (1) in the ignition of an autoimmune-mediated inflammation having neurodevelopmental consequences for their children (autoimmune-priming-attack hypothesis) and (2) has a potential impact on the later manifestation of psychiatric disorders. Through this narrative review, we propose a diagnostic pathway for the clinical diagnosis of a potentially autoimmune origin of psychiatric symptoms in children while considering recent guidelines.Entities:
Year: 2021 PMID: 34057596 DOI: 10.1007/s00702-021-02354-8
Source DB: PubMed Journal: J Neural Transm (Vienna) ISSN: 0300-9564 Impact factor: 3.575